1. Home
  2. JAGX vs KRKR Comparison

JAGX vs KRKR Comparison

Compare JAGX & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

N/A

Current Price

$0.87

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Logo 36Kr Holdings Inc.

KRKR

36Kr Holdings Inc.

N/A

Current Price

$3.00

Market Cap

5.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
KRKR
Founded
2013
2010
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.6M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
JAGX
KRKR
Price
$0.87
$3.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
104.5K
10.0K
Earning Date
04-07-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
N/A
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$2.50
52 Week High
$8.00
$21.36

Technical Indicators

Market Signals
Indicator
JAGX
KRKR
Relative Strength Index (RSI) 24.13 57.27
Support Level $0.60 $2.84
Resistance Level $0.99 $3.25
Average True Range (ATR) 0.09 0.22
MACD 0.03 0.04
Stochastic Oscillator 9.01 71.21

Price Performance

Historical Comparison
JAGX
KRKR

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in the PRC.

Share on Social Networks: